Transplant Biomedicals, CataloniaBio & HealthTech member, announces the positive results of the clinical trial of Vivian®, a medical device used for the transportation and preservation of kidneys.
The results show an excellent safety profile with no events directly related with the use of Vivian® and no organs being discarded before implantation.
The study included Hospital Clínic Barcelona, Vall d’Hebron Hospital and Bellvitge Hospital.
Dr Fritz Diekmann, Head of Renal Transplant Unit at Hospital Clinic and principal investigator of the study, commented: “These results are very encouraging for patients undergoing kidney transplantation and surpasses our clinical daily experience and those reported in the literature in comparison to static cold storage”.
“Our disrupting platform can play a relevant role in addressing the current unmet medical needs not covered by the standard-of-care in solid organ preservation, static cold storage” said Dr Carmen Peralta, co-founder and CSO of Transplant Biomedicals.
Last 20 June, Transplant Biomedicals received the IED Design Awards 2019 for the best proposal for entrepreneurship in the management category. Dr Peralta and Joan Salgado, CEO of the company, attended the gala in Madrid.
Comments